JAMA scandal and Ketek approval raise questions about big pharma's influence

Become a Fan

SAVE AS FAVORITE

VIEW FAVORITES

By Martha Rosenberg (about the author)

Become a Fan (41 fans) -- Page 2 of 2 page(s)

opednews.com

The FDA also blocked publication of Graham's Vioxx paper in the Lancet soon after his congressional testimony and termed his work "junk science."

"It is no secret that Dr. Graham was and is a critic of the FDA," Grassley wrote Inspector General Daniel Levinson. "However, that does not mean the FDA should scheme with drug sponsors to discredit its own employees."

Maybe they thought the relationship was irrelevant.

-

1 | 2

Martha Rosenberg is a health reporter and commentator whose work has appeared in Consumers Digest, the Boston Globe, San Francisco Chronicle, Chicago Tribune, New Orleans Times-Picayune, Los Angeles Times, Providence Journal and Newsday. She serves (more...)

The views expressed in this article are the sole responsibility of the author
and do not necessarily reflect those of this website or its editors.

Contact Author

Contact Editor

View Authors' Articles

Share this page: (what's this?) Tell a Friend:

(More...)

Comments

The time limit for entering new comments on this article has expired.

This limit can be removed. Our paid membership program is designed to give you many benefits, such as removing this time limit. To learn more, please click here.

No comments